Last results 31 Jul 2026Next reporting 5 Nov 2026
Moderna, Inc.
I · AI Analysis
The brief
Moderna uses messenger RNA technology to develop vaccines and therapies across respiratory diseases (COVID-19, RSV, seasonal flu), latent viruses (cytomegalovirus, Epstein-Barr virus, HIV), oncology (personalized cancer vaccines and therapeutics), and rare diseases [Yahoo Finance]. The company employs approximately 4,700 people and has strategic partnerships with Merck, Vertex Pharmaceuticals, and others [Yahoo Finance].
Moderna is a biotechnology company headquartered in Cambridge, Massachusetts, that develops messenger RNA medicines, most notably its COVID-19 vaccine [Yahoo Finance]. The company is expanding into cancer treatments, with a melanoma vaccine in late-stage trials showing positive results when combined with an existing cancer drug [Wall Street Journal]. Despite recent stock gains and a $79.4 billion market cap, the company reported trailing-twelve-month revenue of $2.2 billion through 30 June 2026 with deeply negative margins: operating margin of -149.0% and net margin of -141.4% [Yahoo Finance].
Moderna is deeply unprofitable with negative operating and net margins exceeding -140%, despite a $79.4 billion market cap [Yahoo Finance].
Sentinellis health
Significant risks
2.4/10
7.5+ strong · 4.5–7.5 moderate · under 4.5 weak
Profitability
Returns on capital
Growth & momentum
Balance sheet
Cash generation
Value creation
Sentinellis calculation from the published statements — not a score reported by any data source. Each category is scored on the checks that had data; missing inputs are excluded rather than counted as failures.
Market capitalisation
$79.4B
Revenue (TTM)
$2.2B
Explainers
How we read these numbers
Plain-English guides · no account needed
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
ReadPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
ReadAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
ReadII · Recent news
What moved
6 stories · ranked by relevance
- Company2026-09-25
Moderna CEO’s Realistic Approach to Innovation
Wall Street Journal
- Company2026-09-27
Why Moderna (MRNA) Is Up 29.1% After Melanoma Vaccine Success And Middle East Expansion Talks
Simply Wall St.
- Company2026-09-27
Moderna (MRNA) Held Investment Talks With The UAE Government
Simply Wall St.
- Company2026-09-25
Moderna Stock Jumped 7% Thursday. The Real Test Comes at ESMO on October 24. - Yahoo Finance
Yahoo Finance
- Company2026-09-28
MRNA Stock Eyes Best Year Ever: Analyst Calls China’s AI Drug Lead ‘Baseless’ As Moderna Awaits Cancer Data
Stocktwits
- Company2026-09-28
Moderna Aktie aktuell im Rückgang - Kursentwicklung am 28.09.2026 - Wallstreet Online
Wallstreet Online
Premium · Free with any account
Four senior insiders sold $49.2 million on the open market over the past 90 days with no offsetting open-market purchases, including CEO Stéphane Bancel selling $28.7 million and President Stephen Hoge selling $15.3 million [SEC Form 4]. While these sales often follow option exercises and may be planned or tax-driven, the concentration and size are notable.
Risks
4
Opportunities
4
Red flags
3
Leadership
10
10 more findings in the full report — free with any account.
Unlock the full Moderna, Inc. analysis
Create a free account to access the complete AI-generated report with inline citations.
- 4 risks, 4 opportunities and 3 red flags — each with its source
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
III · Related
You might also read
Same sector · Healthcare — or comparable health
Want this for your watchlist?